Related Content
July 10, 2023 โ Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...
July 10, 2023
January 4, 2022 โ The U.S. Food and Drug Administration (FDA) has cleared Novartis' inclisiran (Leqvio), the first small ...
January 04, 2022
May 15, 2021 โ The combination heart failure drug sacubitril/valsartan (Entresto) did not significantly reduce the rate ...
May 15, 2021
November 16, 2020 โ Novartis announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and -11 ...
November 16, 2020
October 5, 2020 โ The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In ...
October 05, 2020
September 4, 2019 โ Novartis announced results from two new clinical trials evaluating improvement in heart structure ...
September 04, 2019
September 19, 2017 โ The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 19, 2017February 9, 2016 โ Cigna has entered into an outcomes-based contract with the pharmaceutical company Novartis for the ...
February 09, 2016
September 16, 2015 โ The Institute for Clinical and Economic Review (ICER) has released a new report offering a ...
September 16, 2015October 15, 2014 โ Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...
October 15, 2014